Form 4: Clover Health Insider Reports RSU Vesting

Clover Health Investments Corp. insider Jamie L. Reynoso reports acquisition of 159,384 Class A common stock shares via restricted stock unit vesting.

Summary

• Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp., reported a transaction on April 1, 2026.
• This transaction involved the acquisition of 159,384 shares of Class A common stock.
• These shares were acquired through the vesting of restricted stock units (RSUs).
• The RSUs are subject to a vesting schedule: 25% vest on April 1, 2027, with the remainder vesting quarterly over the following three years, fully vesting by April 1, 2030.
• Following this transaction, Reynoso beneficially owns 2,876,119 shares of Class A common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard RSU vesting for an executive and does not indicate new buying or selling pressure beyond the planned compensation structure.

Positives

• Insider acquisition of shares through RSU vesting indicates continued commitment and potential alignment with company performance.
• The vesting schedule suggests a long-term incentive structure for key management.

Risks

• The vesting of RSUs is contingent upon continued service, meaning any departure before vesting dates would result in forfeiture of unvested shares.
• The value of the acquired shares is subject to market fluctuations of Clover Health's Class A common stock.

Future Outlook

The RSUs will continue to vest over a period extending to April 1, 2030, subject to continued employment.

Industry Context

StockSavvy.ai notes that insider transactions, particularly the acquisition of equity through RSU vesting, are common in the health insurance and technology sectors as a means to attract and retain executive talent. The structured vesting schedule is typical for aligning long-term performance with executive compensation.

Stakeholder Impact

• Shareholders: The vesting of RSUs does not directly impact share price in the short term but represents an ongoing compensation expense and potential future dilution if shares are issued from treasury or new shares are created.
• Employees: Reinforces the company's compensation strategy for key executives.
• Management: Jamie L. Reynoso's beneficial ownership increases, aligning their financial interests with the company's long-term success.

Next Steps

• Continued vesting of RSUs according to the schedule through April 1, 2030.
• Monitoring of Clover Health's stock performance and its impact on the value of vested and unvested RSUs.

Key Dates

Keywords

Clover Health Investments, CLOV, Form 4, Insider Transaction, RSU Vesting, Class A Common Stock, Jamie L. Reynoso, Beneficial Ownership